David A. Oluwo

FDA investigator · also recorded as Sets David A. Oluwo, He David A. Oluwo

Appears on 27 documents from 2017 to 2026, most often at sites in Maryland. Most often cites production record review (21 CFR 211.192).

27
Documents on file
3.7
Observations per 483
2017
First seen
2026
Most recent

What they cite most

From 100 observations

Activity by year

2017: 1, 2018: 3, 2019: 3, 2020: 1, 2021: 2, 2022: 1, 2023: 5, 2024: 6, 2025: 2, 2026: 3

Where

Maryland 7 · Pennsylvania 7 · Virginia 5 · New Jersey 3 · Canada 2 · Finland 1

Is David A. Oluwo coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

27 documents, newest first
FirmOpen
483 Granules Pharmaceuticals Inc.Apr 3, 2026 · Chantilly, Virginia
483 Aphena Pharma Solutions - Maryland, LLCFeb 20, 2026 · Easton, Maryland
483 Verinova LPJan 23, 2026 · WestDeptford, New Jersey
483 C.B. Fleet Company, Inc.Apr 18, 2025 · Lynchburg, Virginia
483 AG Essence IncFeb 26, 2025 · Sandston, Virginia
483 Invaderm CorporationOct 17, 2024 · Somerset, New Jersey
483 HOVIONE FARMACIENCIA, S.A.Jun 28, 2024 · Loures, Portugal

About this profile

What does David A. Oluwo inspect?

David A. Oluwo appears on 27 documents on file covering 25 sites, most often in Maryland.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.160 and 21 CFR 211.22.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for David A. Oluwo is dated Apr 3, 2026.